viimane versioon :
19/11/2024
uurimisrühmad - Du pont Critical Care, Pharmaceutical Development Department   pdf  
Ameerika ühendriigid
farmaatsialaboratoorium
Du pont Critical Care, Pharmaceutical Development Department
Waukegan
Email
Viited   Viited   (2)  
1
Stability of esmolol hydrochloride and sodium nitroprussiate in intravenous admixtures.
Karnatz NN, Wong J, Baaske DM, Johnson JH, Speicher ER, Herbranson DE. ()
Am J Hosp Pharm - 1989 - ; 46: 101-104.
2
Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
Karnatz NN, Wong J, Kesler H, Baaske DM, Speicher ER. ()
Am J Hosp Pharm - 1988 - ; 45: 368-371.

ingredientide nimekiri   molekulid uuritud   (4)  
beetablokaator Süsteravim Esmolol hydrochloride
analgeetikum Süsteravim Fentanyl citrate
analgeetikum Süsteravim Morphine sulfate
vasodilataator Süsteravim Nitroprusside sodium

  Mentions Légales